Medical News

[ Extractables And Leachables Conference 15-17 May, 2012 Baltimore, MD - Conference Agenda Announced ]

Extractables And Leachables Conference 15-17 May, 2012 Baltimore, MD - Conference Agenda Announced

Leading E&L conference organizers Smithers Rapra and Smithers Pira announce the agenda for Extractables and Leachables USA 2012 Extractables and leachables are becoming an ever increasing area of regulatory scrutiny, which can be attributed to a number of product recalls associated with leachables. Greater knowledge, understanding and awareness over the years has resulted in this focus expanding from OINDPs (Orally Inhaled and Nasal Drug Products) to multiple drug product types, as well as to medical devices. Regulatory bodies, and working groups, continually drive the needs for harmonized approaches and ever-evolving best practices and improved guidance and recommendations in this area. Coming to Baltimore, MD on 15-17 May 2012, Extractables and Leachables USA 2012 is a launch event for organizers Smithers Rapra and Smithers Pira following their successful European E&L events, and will provide a unique forum for delegates to come together to discuss all of the current E&L issues facing the pharmaceutical industry.

Achieving Market Access Maximizing Commercial Performance In Turkey, Middle East North Africa Conference, 14-15 June 2012, Turkey

This event will provide participants with a broader overview, as well as specific detail of the market access, pricing and reimbursement environment in the region. Furthermore attendees will understand how to communicate with, engage and provide added-value to different stakeholders in order to enhance commercial, marketing performance and sales force effectiveness in key countries such as Turkey, Egypt, Saudi Arabia, United Arab Emirates, Jordan, Algeria and Morocco. A thorough understanding of this dynamic region will be achieved by hearing the perspectives of payers, government officials and key opinion leaders from academia, as well as learning from the case-study experiences from pharma industry veterans who have successfully overcome challenges to launch innovative medicines in this exciting region.

KOL Management MSL Best Practice In Europe Conference, 2-3 July 2012, Basel, Switzerland

SMi are proud to present their 4th annual European Conference on KOL Management & MSL Best Practice in Europe, to be held on 2nd & 3rd July 2012 in Basel, Switzerland. The 2012 event will bring together senior Pharma executives and key opinion leaders to discuss current issues in the field. With presentations from industry representatives from all over the pharmaceutical sector, this event promises to be a unique platform for networking and problem solving. Key Benefits of Attending: Hear from leading industry experts from major pharmaceutical companies about compliance challenges in KOL interaction Consider effective MSL development strategies in orphan disease markets Understand the importance of KOL management in developing countries Discuss with patient advocacy groups how best to build and sustain industry-academia relationships Explore MSL best practice strategies in promotional and marketing activities Learn how best to utilize digital media in KOL management ‚ ®HEAR KEY PRESENTATIONS FROM EXPERTS IN THE FIELD: Key factors in KOL management‚ ®Soren Skovlund, Global Director, Novo Nordisk ‚ ® MSL in Orphan Disease: Hand-in-hand with a targeted sales force‚ ®Andreas Brecht, Medical Science Liaison, Actelion New developments and relationships in continuing medical education (CME)‚ ®Tom Pulles, International Medical Director, Shire KOL management in developing countries, ‚ ®Stephen Toovey, Medical Consultant, Virology, Roche Pharmaceuticals Joint Presentation: Ensuring a successful relationship between Industry & Patients, ‚ ®Keith Allan, Head of Global Product Advocacy, Novartis ‚ ®Susanna Palkonen, Chairman, European Federation of Allergy and Airways Diseases Patients Associations ‚ ® Visit our website here: http://www.

The World Drug Safety Congress Americas, 17-20 April 2012, Boston, USA

Are you fully prepared to overcome the key drug safety challenges? The 4th annual World Drug Safety Congress Americas is fast approaching and once again promises to be an unmissable event for the industry. 8 reasons to attend: High level speaker seniority, including Abbott, AstraZeneca, Genzyme, Roche, Boehringer Ingelheim, Forest Laboratories, Health Canada and Pfizer Quality content that will address the key drug safety issues of relevance to you A proven track record; Building on past success 2012 promises to be better than ever! Packed agenda with over 30 unique and informative sessions, panel discussions, Q&A opportunities and plenty of networking to keep you busy Extensive networking opportunities; Make contact, plan who to talk to and arrange meetings prior to the conference, take part in multiple networking sessions then continue to build those relationships following the event Case studies;

World Virology Microbiology Online Conference Held On April 19-21, 2012: No Travel And In Real Time

Target Meeting is a leading life science conference organizer. They specialize in organizing conferences, symposiums and workshops, which brings together the known researchers, professors and life science suppliers from across the world to debate over the latest developments in biomedical research. The 2012 World Virology & Microbiology Online Conference scheduled to be held on April 19 - 21, 2012. The 12 sessions, which will be spread over three days will discuss Case Studies in Clinical Microbiology, Epidemiology and Microbiology, Cell Biology of Bacteria, Antibacterial Drug Discovery, Virology Molecular Biology & Viral Therapy, Infection and Immunity, Anti-Infection Treatments, HIV Diagnosis and Therapy and many more. More than 50 leading professors and researchers will give oral presentations at the online conference.

Medical News © Nanda
Designer Damodar